Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:44 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 2,496 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Spinal Clear all

Conditions: Spinal Cord Injuries
Interventions: HealthPartners NeuroWell Exercise Program; Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Chronic Pain
Interventions: Boston Scientific WaveWriter SCS System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 22 Years and older
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 13
States / cities: Palm Desert, California • Greenwood Village, Colorado • Clermont, Florida + 10 more

Conditions: B-Cell Non-Hodgkin Lymphoma
Interventions: Anakinra, X-Ray Imaging, Positron Emission Tomography, Computed Tomography, Bone Marrow Aspiration, Bone Marrow Biopsy, Lumbar Puncture, Biospecimen Collection; Biological · Procedure
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Leukemia
Interventions: Blinatumomab, Oncaspar, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin Hydrochloride, Etoposide, Mercaptopurine, Methotrexate, Vincristine; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years to 51 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2035
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Solid Tumors With PTCH1 Loss-of-function Mutations
Interventions: ENV-101 (taladegib); Drug
Lead sponsor: Endeavor Biomedicines, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 16
States / cities: Los Angeles, California • Santa Rosa, California • Tampa, Florida + 13 more

Conditions: Chronic Spinal Cord Injury, Neurogenic Bladder
Interventions: High Dose, Low dose; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Cord Injury, Tetraplegia
Interventions: FIRSTHAND System; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Spinal Cord Injuries
Interventions: Robotic Gait Training, Usual Care Gait Training; Device · Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 16 Years to 85 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Phantom Limb Pain
Interventions: Lower extremity amputation; Procedure
Lead sponsor: North Texas Veterans Healthcare System; Federal
Eligibility: 18 Years and older
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Chronic Pain, Pain, Neuropathic, Neuropathic Pain
Interventions: Spinal Cord Stimulator; Device
Lead sponsor: Ashwin Viswanathan; Other
Eligibility: 22 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Muscular Atrophy
Interventions: 4-aminopyridine, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Brain Tumor, Recurrent, Brain Tumor, Pediatric, Central Nervous System Neoplasms, Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: RRx-001, Temozolomide, Irinotecan; Drug
Lead sponsor: EpicentRx, Inc.; Industry
Eligibility: 1 Year to 21 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Cord Injuries
Interventions: Living Longer and Stronger with SCI, Control; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Metastasis
Interventions: TTF-200M and TTF-200A systems; Device
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Dyspnea, Tetraplegia
Interventions: ipratropium (Atrovent); Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2001
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Spinal Cord Injuries (SCI)
Interventions: Acute Intermittent Hypoxia (AIH); Device
Lead sponsor: Zev Rymer; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Female Sexual Dysfunction, Multiple Sclerosis, Spinal Cord Injury
Interventions: Sympathetic manipulation on sexual arousal in women; Procedure
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Lumbar Spinal Stenosis
Interventions: electric dry needling, manipulation, conventional physical therapy; Other
Lead sponsor: Alabama Physical Therapy & Acupuncture; Other
Eligibility: 50 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Canton, Georgia

Conditions: Juvenile and Adolescent Idiopathic Scoliosis
Interventions: differential rod bending with rod contours (MESA Spinal System); Procedure
Lead sponsor: Rush University Medical Center; Other
Eligibility: 10 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Lumbar Degenerative Disc Disease
Interventions: PureGen Osteoprogenitor Cell Allograft, Autograft bone; Biological · Procedure
Lead sponsor: Alphatec Spine, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Beverly Hills, California

Conditions: Injuries, Pain
Interventions: Comprehensive Medical Management, Spinal Cord Stimulator; Other · Procedure
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Chronic Pain, Hypertension, Diuretics Drug Reactions, SCS
Interventions: Hydrochlorothiazide 12.5mg, Placebo; Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 40 Years to 79 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Chronic Low-back Pain
Interventions: Not listed
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Scoliosis
Interventions: Mechanical hemiepiphysiodesis using the HemiBridge System; Device
Lead sponsor: SpineForm LLC; Industry
Eligibility: 10 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 2
States / cities: Cincinnati, Ohio • Cleveland, Ohio

Search by objective public record fields.

Spinal Cord Injury - Exercise

Paresthesia-Free Fast-Acting Subperception (FAST) Study

Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy

ALL Backbone in AYAs

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation

Hand Function for Tetraplegia

Foundational Ingredients of Robotic Gait Training for People With Spinal Cord Injury During Inpatient Therapy

Incidence of Phantom Limb Pain and Method of Anesthesia After Lower Extremity Amputation

Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation

Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors

Living Longer and Stronger With Spinal Cord Injury (SCI)

A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis

Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia

Spasticity in SCI Following Acute Intermittent Hypoxia

Effects of Spinal Cord Injury on Female Sexual Response

Dry Needling and Spinal Manipulation vs. Conventional PT for Lumbar Spinal Stenosis

3-D Correction of Adolescent Idiopathic Scoliosis (AIS) With Differential Metals

Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)

War Wounded, a Comparison of Two Pain Management Approaches

Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction

Brain Imaging Biomarkers for Response to Spinal Cord Stimulation in Patients With Chronic Low Back Pain

Evaluate Initial Safety of the HemiBridge™ System in Guided Spinal Growth Treatment of Progressive Idiopathic Scoliosis